The 17th edition of the Clinical Trial Supply Chain Europe will be held in Barcelona on March 15- 16. On this occasion, OCEASOFT will unveil OCEAClinic™: a new offer specially designed to meet the needs in cold chain monitoring of stakeholders involved with clinical trials.
Cold chain management is a critical issue for the clinical trials sector, for several reasons:
- the regulatory constraints surrounding these clinical trials are increasingly stringent and numerous (FDA, EMEA, internal audits...),
- the financial stakes are enormous, to the extent of the budgets invested by pharmaceutical companies in increasingly complex and therefore expensive drugs & medicines ,
- temperature excursions have a direct impact on clinical trials' therapeutic efficiency and therefore on patients' health.
To meet the specific needs and challenges of stakeholders involved with clinical trials, OCEASOFT has developed a comprehensive and flexible solution: OCEAClinic™. Based on proven technical and human expertise, OCEAClinic™ enables traceability throughout the supply chain, from investigational product to biological samples collected after administration to the patient. Simplicity, traceability, cost-efficiency, quality, and compliance, combined with a range of adapted services, are the driving forces behind OCEAClinic™. An unique offer designed to optimize:
- patient safety,
- therapeutic efficacy,
- return on investment of years of research,
... thus the overall success of a clinical trial!
Meet the OCEASOFT team at CTS Europe 2017 in Barcelona, Booth #12 and learn more about OCEAClinic™!
Oceasoft SA published this content on 15 March 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 14 March 2017 00:38:10 UTC.
Original documenthttp://www.oceasoft.com/news/preview-meet-oceaclinic
Public permalinkhttp://www.publicnow.com/view/7D2BCDF37EE1EF5E2D6BA7170BC05971715D75F4